17-68531661-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002734.5(PRKAR1A):c.*1212T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.122 in 1,066,036 control chromosomes in the GnomAD database, including 8,001 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.13 ( 1271 hom., cov: 32)
Exomes 𝑓: 0.12 ( 6730 hom. )
Consequence
PRKAR1A
NM_002734.5 3_prime_UTR
NM_002734.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.884
Publications
20 publications found
Genes affected
PRKAR1A (HGNC:9388): (protein kinase cAMP-dependent type I regulatory subunit alpha) cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. This gene encodes one of the regulatory subunits. This protein was found to be a tissue-specific extinguisher that down-regulates the expression of seven liver genes in hepatoma x fibroblast hybrids. Mutations in this gene cause Carney complex (CNC). This gene can fuse to the RET protooncogene by gene rearrangement and form the thyroid tumor-specific chimeric oncogene known as PTC2. A nonconventional nuclear localization sequence (NLS) has been found for this protein which suggests a role in DNA replication via the protein serving as a nuclear transport protein for the second subunit of the Replication Factor C (RFC40). Several alternatively spliced transcript variants encoding two different isoforms have been observed. [provided by RefSeq, Jan 2013]
PRKAR1A Gene-Disease associations (from GenCC):
- Acrodysostosis 1 with or without hormone resistanceInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- acrodysostosis with multiple hormone resistanceInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet
- Carney complex, type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- pigmented nodular adrenocortical disease, primary, 1Inheritance: AD Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics
- acrodysostosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Carney complexInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial atrial myxomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- primary pigmented nodular adrenocortical diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 17-68531661-T-G is Benign according to our data. Variant chr17-68531661-T-G is described in ClinVar as Benign. ClinVar VariationId is 324806.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.143 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.128 AC: 19410AN: 152106Hom.: 1269 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
19410
AN:
152106
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.121 AC: 110432AN: 913812Hom.: 6730 Cov.: 33 AF XY: 0.121 AC XY: 51079AN XY: 421852 show subpopulations
GnomAD4 exome
AF:
AC:
110432
AN:
913812
Hom.:
Cov.:
33
AF XY:
AC XY:
51079
AN XY:
421852
show subpopulations
African (AFR)
AF:
AC:
3200
AN:
19658
American (AMR)
AF:
AC:
281
AN:
3474
Ashkenazi Jewish (ASJ)
AF:
AC:
1023
AN:
10242
East Asian (EAS)
AF:
AC:
1786
AN:
14982
South Asian (SAS)
AF:
AC:
1417
AN:
17146
European-Finnish (FIN)
AF:
AC:
126
AN:
760
Middle Eastern (MID)
AF:
AC:
274
AN:
2110
European-Non Finnish (NFE)
AF:
AC:
98372
AN:
811402
Other (OTH)
AF:
AC:
3953
AN:
34038
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
5017
10033
15050
20066
25083
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4604
9208
13812
18416
23020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.128 AC: 19418AN: 152224Hom.: 1271 Cov.: 32 AF XY: 0.128 AC XY: 9527AN XY: 74440 show subpopulations
GnomAD4 genome
AF:
AC:
19418
AN:
152224
Hom.:
Cov.:
32
AF XY:
AC XY:
9527
AN XY:
74440
show subpopulations
African (AFR)
AF:
AC:
6082
AN:
41530
American (AMR)
AF:
AC:
1661
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
352
AN:
3472
East Asian (EAS)
AF:
AC:
538
AN:
5182
South Asian (SAS)
AF:
AC:
353
AN:
4822
European-Finnish (FIN)
AF:
AC:
1745
AN:
10600
Middle Eastern (MID)
AF:
AC:
44
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8221
AN:
68002
Other (OTH)
AF:
AC:
284
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
843
1685
2528
3370
4213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
255
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Acrodysostosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Carney complex Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.